125 related articles for article (PubMed ID: 398183)
21. The Gemfibrozil Study.
Manninen V
Acta Med Scand Suppl; 1985; 701():83-8. PubMed ID: 3907298
[TBL] [Abstract][Full Text] [Related]
22. The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC).
Børresen AL; Berg K; Dahlén G; Gillnäs T; Ericson C
Artery; 1981; 9(1):77-86. PubMed ID: 7018466
[TBL] [Abstract][Full Text] [Related]
23. Gemfibrozil--a new lipid lowering agent.
Nash DT
J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Jamska B; Nowacki G
Przegl Lek; 1987; 44(12):828-36. PubMed ID: 3330252
[No Abstract] [Full Text] [Related]
25. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception.
Rådberg T; Gustafson A; Skryten A; Karlsson K
Horm Metab Res; 1982 Feb; 14(2):61-5. PubMed ID: 7040192
[TBL] [Abstract][Full Text] [Related]
26. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
Balogh Z; Seres I; Harangi M; Kovács P; Kakuk G; Paragh G
Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
[TBL] [Abstract][Full Text] [Related]
27. Gemfibrozil, lipids, and coronary risk.
Rifkind BM
N Engl J Med; 1987 Nov; 317(20):1279-81. PubMed ID: 3313042
[No Abstract] [Full Text] [Related]
28. Clinical results with gemfibrozil.
Pickering JE
Am J Cardiol; 1983 Aug; 52(4):39B-40B. PubMed ID: 6351579
[No Abstract] [Full Text] [Related]
29. Gemfibrozil treatment: a comparison with clofibrate.
Howard AN; Ghosh P
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
[TBL] [Abstract][Full Text] [Related]
30. The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus.
Chang DM; Fuh MM; Jeng CY; Shian LR
Taiwan Yi Xue Hui Za Zhi; 1986 May; 85(5):443-50. PubMed ID: 3463653
[No Abstract] [Full Text] [Related]
31. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
Manninen V; Elo MO; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
JAMA; 1988 Aug; 260(5):641-51. PubMed ID: 3164788
[TBL] [Abstract][Full Text] [Related]
32. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
Torstila I; Kaukola S; Manninen V; Virtamo J; Mälkönen M
Acta Med Scand Suppl; 1982; 668():123-9. PubMed ID: 6188330
[TBL] [Abstract][Full Text] [Related]
33. Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
Manninen V; Mälkönen M; Eisalo A; Virtamo J; Tuomilehto J; Kuusisto P
Acta Med Scand Suppl; 1982; 668():82-7. PubMed ID: 6762809
[No Abstract] [Full Text] [Related]
34. Change in composition of high density lipoprotein during gemfibrozil therapy.
Sorisky A; Ooi TC; Simo IE; Meuffels M; Hindmarsh JT; Nair R
Atherosclerosis; 1987 Oct; 67(2-3):181-9. PubMed ID: 3118893
[TBL] [Abstract][Full Text] [Related]
35. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
Lewis JE
Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156
[TBL] [Abstract][Full Text] [Related]
36. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus].
Markoski S
Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910
[TBL] [Abstract][Full Text] [Related]
37. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
Manninen V
Am J Cardiol; 1983 Aug; 52(4):35B-38B. PubMed ID: 6351578
[No Abstract] [Full Text] [Related]
38. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
Vega GL; Grundy SM
JAMA; 1985 Apr; 253(16):2398-403. PubMed ID: 3856692
[TBL] [Abstract][Full Text] [Related]
39. A pilot study of the effect of Gemfibrozil on some haematological parameters.
O'Brien JR; Etherington MD; Shuttleworth RD; Adams CM; Middleton JE; Goodland FC
Thromb Res; 1982 May; 26(4):275-9. PubMed ID: 6955993
[TBL] [Abstract][Full Text] [Related]
40. Hyperlipoproteinemia, atherosclerosis and gemfibrozil.
Nash DT
Angiology; 1982 Sep; 33(9):594-602. PubMed ID: 6957155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
